Its benefit depends heavily on exercise and baseline carnitine status: it is most useful for physically active people, vegetarians, and those with lower dietary intake, and shows little benefit as a standalone, sedentary-use supplement
Store supplements in a cold, dry place
While sommarutide is undoubtedly an exciting potential treatment option, there is still a lack of clear clinical data on the mechanism of action of GLP-1 agonists in NASH, such as whether GLP-1 agonists have a direct, independent role in improving NASH, or simply by improving body weight, insulin resistance, and so on
In July, Wegovy arrived
Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February